Abstract
Poor penetration of therapeutic drugs into tumors is a major challenge in anticancer therapy, especially in solid tumors, leading to reduced therapeutic efficacy in vivo. In the study, we used a new tumor-penetrating peptide, CRGDK, to conjugate onto the surface of doxorubicin encapsulated nanoscale micelles. The CRGDK peptide triggered specific binding to neuropilin-1, leading to enhanced cellular uptake and cytotoxicity in vitro and highly accumulation and penetration in the tumors in vivo.
Original language | English |
---|---|
Pages (from-to) | 2528-2534 |
Number of pages | 7 |
Journal | Nano Letters |
Volume | 13 |
Issue number | 6 |
DOIs | |
Publication status | Published - 12 Jun 2013 |
Externally published | Yes |
Keywords
- Targeted drug delivery
- doxorubicin
- micelle
- neuropilin-1
- tumor-penetrating peptide